These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 10987994)

  • 1. Non-stealth and stealth solid lipid nanoparticles (SLN) carrying doxorubicin: pharmacokinetics and tissue distribution after i.v. administration to rats.
    Fundarò A; Cavalli R; Bargoni A; Vighetto D; Zara GP; Gasco MR
    Pharmacol Res; 2000 Oct; 42(4):337-43. PubMed ID: 10987994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correction: Santonocito et al. Astaxanthin-Loaded Stealth Lipid Nanoparticles (AST-SSLN) as Potential Carriers for the Treatment of Alzheimer's Disease: Formulation Development and Optimization.
    Santonocito D; Raciti G; Campisi A; Sposito G; Panico A; Siciliano EA; Sarpietro MG; Damiani E; Puglia C
    Nanomaterials (Basel); 2023 Dec; 13(24):. PubMed ID: 38133068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stealth Migrations: Trillions of tiny animals may be coordinating their daily movements in ways that affect every organism on the planet.
    Harmon Courage K
    Sci Am; 2022 Aug; 327(2):48. PubMed ID: 39016801
    [No Abstract]   [Full Text] [Related]  

  • 4. Intravenous administration to rabbits of non-stealth and stealth doxorubicin-loaded solid lipid nanoparticles at increasing concentrations of stealth agent: pharmacokinetics and distribution of doxorubicin in brain and other tissues.
    Zara GP; Cavalli R; Bargoni A; Fundarò A; Vighetto D; Gasco MR
    J Drug Target; 2002 Jun; 10(4):327-35. PubMed ID: 12164381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Solid lipid nanoparticles for parenteral drug delivery.
    Wissing SA; Kayser O; Müller RH
    Adv Drug Deliv Rev; 2004 May; 56(9):1257-72. PubMed ID: 15109768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation and characteristics of lipid nanoemulsion formulations loaded with doxorubicin.
    Jiang SP; He SN; Li YL; Feng DL; Lu XY; Du YZ; Yu HY; Hu FQ; Yuan H
    Int J Nanomedicine; 2013; 8():3141-50. PubMed ID: 23990722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Doxorubicin-loaded solid lipid nanoparticles to overcome multidrug resistance in cancer therapy.
    Kang KW; Chun MK; Kim O; Subedi RK; Ahn SG; Yoon JH; Choi HK
    Nanomedicine; 2010 Apr; 6(2):210-3. PubMed ID: 20060074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipid nanoemulsions loaded with doxorubicin-oleic acid ionic complex: characterization, in vitro and in vivo studies.
    Zhang X; Sun X; Li J; Zhang X; Gong T; Zhang Z
    Pharmazie; 2011 Jul; 66(7):496-505. PubMed ID: 21812324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coencapsulated doxorubicin and bromotetrandrine lipid nanoemulsions in reversing multidrug resistance in breast cancer in vitro and in vivo.
    Cao X; Luo J; Gong T; Zhang ZR; Sun X; Fu Y
    Mol Pharm; 2015 Jan; 12(1):274-86. PubMed ID: 25469833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Solid lipid nanoparticles for potential doxorubicin delivery in glioblastoma treatment: preliminary in vitro studies.
    Battaglia L; Gallarate M; Peira E; Chirio D; Muntoni E; Biasibetti E; Capucchio MT; Valazza A; Panciani PP; Lanotte M; Schiffer D; Annovazzi L; Caldera V; Mellai M; Riganti C
    J Pharm Sci; 2014 Jul; 103(7):2157-2165. PubMed ID: 24824141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Doxorubicin loading, release, and stability of polyamidoamine dendrimer-coated magnetic nanoparticles.
    Rouhollah K; Pelin M; Serap Y; Gozde U; Ufuk G
    J Pharm Sci; 2013 Jun; 102(6):1825-1835. PubMed ID: 23558592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Doxorubicin-loaded nanoparticles: new advances in breast cancer therapy.
    Prados J; Melguizo C; Ortiz R; Vélez C; Alvarez PJ; Arias JL; Ruíz MA; Gallardo V; Aranega A
    Anticancer Agents Med Chem; 2012 Nov; 12(9):1058-70. PubMed ID: 22339066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prolonged circulation time and enhanced accumulation in malignant exudates of doxorubicin encapsulated in polyethylene-glycol coated liposomes.
    Gabizon A; Catane R; Uziely B; Kaufman B; Safra T; Cohen R; Martin F; Huang A; Barenholz Y
    Cancer Res; 1994 Feb; 54(4):987-92. PubMed ID: 8313389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topical Skin Cancer Therapy Using Doxorubicin-Loaded Cationic Lipid Nanoparticles and lontophoresis.
    Huber LA; Pereira TA; Ramos DN; Rezende LC; Emery FS; Sobral LM; Leopoldino AM; Lopez RF
    J Biomed Nanotechnol; 2015 Nov; 11(11):1975-88. PubMed ID: 26554156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation and characterization of solid lipid nanoparticles loaded with doxorubicin.
    Subedi RK; Kang KW; Choi HK
    Eur J Pharm Sci; 2009 Jun; 37(3-4):508-13. PubMed ID: 19406231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Curcumin in treatment of hematological cancers: Promises and challenges.
    Entezari M; Tayari A; Paskeh MDA; Kheirabad SK; Naeemi S; Taheriazam A; Dehghani H; Salimimoghadam S; Hashemi M; Mirzaei S; Samarghandian S
    J Tradit Complement Med; 2024 Mar; 14(2):121-134. PubMed ID: 38481552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Design-Conversed Strategy Establishes the Performance Safe Space for Doxorubicin Nanosimilars.
    Nagpal S; Png Yi Jie J; Malinovskaya J; Kovshova T; Jain P; Naik S; Khopade A; Bhowmick S; Shahi P; Chakra A; Bhokari A; Shah V; Gelperina S; Wacker MG
    ACS Nano; 2024 Feb; 18(8):6162-6175. PubMed ID: 38359902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Strategies for enhanced bioavailability of oxime reactivators in the central nervous system.
    Prchalova E; Kohoutova Z; Knittelova K; Malinak D; Musilek K
    Arch Toxicol; 2023 Nov; 97(11):2839-2860. PubMed ID: 37642747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanoparticles in Drug Delivery: From History to Therapeutic Applications.
    Afzal O; Altamimi ASA; Nadeem MS; Alzarea SI; Almalki WH; Tariq A; Mubeen B; Murtaza BN; Iftikhar S; Riaz N; Kazmi I
    Nanomaterials (Basel); 2022 Dec; 12(24):. PubMed ID: 36558344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Recent Update: Solid Lipid Nanoparticles for Effective Drug Delivery.
    Pandey S; Shaikh F; Gupta A; Tripathi P; Yadav JS
    Adv Pharm Bull; 2022 Jan; 12(1):17-33. PubMed ID: 35517874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.